Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...
The era of value- and evidence-based care has come to oncology practice. Third-party payers approve treatment plans according to expert guidelines such as those of the National Comprehensive Cancer ...
We surveyed medical oncologists involved in the care of a population-based cohort of patients with lung cancer from the CanCORS (Cancer Care Outcomes Research and Surveillance) study. Physicians were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results